Cannabis oil is used for a range of health purposes, from managing chronic pain and reducing seizures to easing chemotherapy-related nausea and relieving muscle spasticity in neurological conditions. Some of these uses are backed by rigorous clinical trials and FDA-approved medications, while others rely on earlier-stage evidence. Here’s what the research actually shows for each major use.
Chronic Pain
Pain relief is the most common reason people turn to cannabis oil. Your body has its own built-in cannabinoid system, called the endocannabinoid system, that naturally regulates pain perception. When compounds in cannabis oil interact with this system, they reduce the release of chemical signals that amplify pain while activating circuits that dampen it. A second type of receptor, found mainly on immune cells, works by dialing down inflammation, suppressing inflammatory chemicals, and protecting nerve tissue from damage.
Clinical trials show that oils combining both THC and CBD tend to outperform THC alone for pain. In a study of 177 patients with cancer pain already taking strong opioids, 38% of those using a THC-CBD combination achieved at least a 30% pain reduction, compared with 21% in the THC-only group. For nerve injury pain, both THC-CBD and THC-only oils reduced pain scores by about 1.3 points on a 10-point scale, roughly double the improvement seen with placebo. CBD on its own appears less effective for pain: in one head-to-head comparison, only 17% of patients maintained their pain relief when switched to CBD alone.
Epilepsy and Seizures
This is the best-established medical use for cannabis oil. The FDA has approved a purified CBD product (Epidiolex) for treating seizures in two severe childhood epilepsy conditions, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years and older.
The evidence behind this approval is strong. In a trial of patients with Lennox-Gastaut syndrome, CBD reduced the frequency of drop seizures (the type most likely to cause falls and injuries) by about 42% at the higher dose, compared with a 17% reduction with placebo. One in four patients on the higher dose saw their seizure frequency drop by 75% or more. A separate trial in 120 children with Dravet syndrome found CBD reduced seizure frequency by roughly 22% more than placebo over 14 weeks. These aren’t cures, but for conditions that often resist conventional medications, these reductions are meaningful.
Chemotherapy-Related Nausea
Cannabis-based medications have been used for chemotherapy-related nausea since the 1980s. The FDA has approved two synthetic cannabinoid drugs for this purpose: dronabinol (sold as Marinol and Syndros) and nabilone (Cesamet). Both are recommended specifically for nausea that doesn’t respond to standard anti-nausea drugs.
In clinical testing, patients using a THC-CBD combination reported significantly lower nausea scores than those on placebo (averaging 2.1 versus 3 on a standardized scale). The combination also nearly doubled the rate of “complete response,” meaning no vomiting and no significant nausea, from 14% to 25%. Dronabinol is also approved for treating appetite loss and weight loss in people with AIDS.
Multiple Sclerosis and Spasticity
Muscle stiffness and spasms are among the most disabling symptoms of multiple sclerosis, and cannabis oil has shown consistent benefits here. An oral spray containing both THC and CBD (nabiximols) was linked to a 51% reduction in MS-related spasticity in one study, with patients also reporting a 20% improvement on a numerical rating scale. Multiple trials have confirmed a statistically significant reduction in spasticity scores compared with placebo.
The effects on mobility are more mixed. Most studies found no significant improvement in walking speed or daily-activity scores, though one recent study did report short-term benefits for balance and walking ability. Cannabis oil appears to help with the subjective experience of tightness and spasm more than it improves measurable physical function.
Skin Conditions
Cannabinoid receptors exist throughout the skin, and topical cannabis oil has shown anti-inflammatory, anti-itch, wound-healing, and antimicrobial effects in laboratory studies. The connection to psoriasis is particularly interesting because cannabinoids can directly suppress the overactive immune cells (T-cells) and excessive skin cell growth that drive the disease.
Clinical data is still limited, but early results for itching are striking. In a study of 21 patients with severe itching related to kidney disease, applying a cannabinoid-containing cream twice daily for three weeks completely eliminated itching in over 38% of participants. Another 52% reported significant improvement. Across studies, topical cannabinoid products have averaged an 86% reduction in subjective itching scores.
Anxiety and Sleep
Many people use CBD oil for anxiety and insomnia, but the clinical evidence here is thinner than for other uses. A randomized controlled trial tested 150 mg of CBD taken under the tongue 60 minutes before bed in people with moderate to severe insomnia. The results were underwhelming for sleep itself: CBD performed similarly to placebo on most sleep measurements. Participants did, however, report greater overall well-being, suggesting CBD’s effects on anxiety and mood may be more prominent than its direct sleep benefits.
This points to a pattern in the research. CBD’s calming effects are real enough that people notice them, but they don’t consistently translate into the kind of measurable sleep improvements seen with established sleep aids.
CBD Oil vs. THC Oil
Cannabis oil is a broad term that covers products with very different compositions. The two key compounds are CBD (cannabidiol) and THC (tetrahydrocannabinol), and they serve different purposes.
CBD-dominant oils are primarily used for seizure disorders, and guidelines recommend high CBD-to-THC ratios to minimize the psychoactive and other side effects of THC. For pain, the evidence favors combination products containing both THC and CBD over either compound alone. THC is the more effective component for nausea and appetite stimulation, which is why the FDA-approved anti-nausea medications are THC-based. For spasticity, a roughly equal THC-CBD combination has the most clinical support.
Safety and Side Effects
Cannabis oil is not side-effect free. The most commonly reported problems with CBD include drowsiness, diarrhea, decreased appetite, and irritability. These typically improve when the dose is reduced or stopped.
Liver injury is the most serious known risk. During the approval process for Epidiolex, blood tests revealed signs of liver damage in some patients, including those not taking other liver-affecting medications. This risk is manageable under medical supervision but harder to monitor when people use unregulated CBD products on their own. CBD also affects the same liver enzyme pathways that process many common medications, meaning it can increase or decrease the effectiveness of other drugs you take. Combining CBD with alcohol, sedatives, or anti-anxiety medications increases the risk of excessive drowsiness. Animal studies have also raised concerns about potential harm to male fertility.
Legal Status in the United States
Under federal law, cannabis products fall into two categories. Hemp-derived products, defined as having no more than 0.3% THC, are legal. Anything above that threshold is classified as marijuana and remains a Schedule I controlled substance. In December 2025, President Trump issued an executive order directing the Attorney General to move marijuana from Schedule I to Schedule III, though final action on that rescheduling has not yet been taken.
Congress also passed legislation in November 2025 changing how hemp THC is measured. The new definition will be based on total THC concentration rather than just one specific form (delta-9 THC), closing a loophole that allowed some potent products to be sold as hemp. This updated definition is scheduled to take effect in November 2026. State laws vary widely, so the legality of any particular cannabis oil product depends on both its THC content and where you live.